Condition

Metastatic Castration-Resistant Prostate Carcinoma clinical trials and research

• 7Clinical trials
• 1Country

Newest Metastatic Castration-Resistant Prostate Carcinoma clinical trials

All recruiting trials (7)

• Testing Different Dosing Schedules of Lutetium-177Lu PSMA RLT in Advanced Prostate Cancer

  This trial tests if spacing out Lutetium-177Lu PSMA RLT doses adapts to the patient and improves quality of life without shortening life in men with advanced, hormone-resistant prostate cancer.

  Recruiting at 105 sites Phase 3 Alliance for Clinical Trials in Oncology · Anchorage, Alaska and 141 other locations · NCT07200830

• SPECT/CT imaging to measure radiation dose during Pluvicto (177Lu‑PSMA‑617) treatment

  This project will use SPECT/CT scans to see if measured radiation doses to tumors and normal organs predict response and side effects in men with metastatic castration‑resistant prostate cancer receiving 177Lu‑PSMA‑617 (Pluvicto).

  Recruiting University of Michigan Rogel Cancer Center · Ann Arbor, Michigan · NCT07096999

• New ACK1-blocking pill (R)-9bMS for advanced prostate cancer

  This phase 1 trial will test whether the oral ACK1 inhibitor (R)-9bMS is safe and tolerable in men with metastatic castration-resistant prostate cancer who no longer respond to enzalutamide or abiraterone.

  Recruiting Phase 1 TechnoGenesys, Inc. · Madison, Wisconsin · NCT06705686

• Intensified treatment for advanced prostate cancer using 177Lu-PSMA-617

  This study is testing a new treatment called 177Lu-PSMA-617 for men with advanced prostate cancer that doesn't respond to hormone therapy to see if it works better than the usual treatments.

  Recruiting at 2 sites Phase 2 University of Washington · San Francisco, California and 2 other locations · NCT06526299

• Cell therapy combined with enzalutamide for advanced prostate cancer

  This study is testing a new combination of cell therapy and a medication called enzalutamide to see if it helps people with advanced prostate cancer live better and longer.

  Recruiting Phase 1/2 Fred Hutchinson Cancer Center · Seattle, Washington · NCT06236139

• Using a new imaging test for prostate cancer before treatment

  This study is testing a new imaging scan to see how well it can show the spread of advanced prostate cancer before starting treatment.

  Recruiting at 2 sites Phase 4 Brigham and Women's Hospital · Boston, Massachusetts and 1 other locations · NCT06099093

• Using abemaciclib before a radioactive treatment for advanced prostate cancer

  This study is testing if taking abemaciclib before a radioactive treatment can help men with advanced prostate cancer feel better and improve their treatment results.

  Recruiting Phase 1/2 University of California, San Francisco · San Francisco, California · NCT05113537

Related topics

Quick answers

How many Metastatic Castration-Resistant Prostate Carcinoma clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 3: 1, Phase 2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →